| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wentworth Kerry | CHIEF REGULATORY OFFICER | C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 18 Jun 2025 | 0001369453 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Purchase | $46,540 | +26,000 | $1.79 | 26,000 | 16 Jun 2025 | Direct | ||
| transaction | NUVB | Class A Common Stock | Purchase | $43,200 | +24,000 | +92% | $1.80 | 50,000 | 16 Jun 2025 | Direct |